Law360, New York (November 17, 2011, 6:08 PM ET) -- A Kentucky state jury has handed Watson Pharmaceuticals Inc. a complete defense verdict in a case alleging it reported inflated average wholesale drug prices to Medicaid programs, the company announced Wednesday.
Since July 2002, Watson and certain of its subsidiaries, as well as numerous other drugmakers, have been named as defendants in various state and federal court actions alleging that these companies unlawfully set and reported inflated drug values that have damaged state Medicare programs, which use those benchmarks to reimburse pharmacies and dispense drugs to...
Watson Ducks Ky. Drug Price Inflation Suit
To view the full article, take a free trial now.
